Intraperitoneal fat and insulin resistance in obese adolescents

Obesity

Volumn 18, Issue 2, 2010, Pages 402-409

  Wilson, Darrell M ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDIABETIC AGENT; BIOLOGICAL MARKER; HIGH DENSITY LIPOPROTEIN; IGFBP1 PROTEIN, HUMAN; INSULIN; METFORMIN; SOMATOMEDIN BINDING PROTEIN 1; TRIACYLGLYCEROL;

ABDOMINAL FAT; ADOLESCENT; AFRICAN AMERICAN; ANTHROPOMETRY; ARTICLE; BLOOD; BODY MASS; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; ETHNOLOGY; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; MALE; METABOLISM; MULTICENTER STUDY; OBESITY; PATHOPHYSIOLOGY; PATIENT SELECTION; PHOTON ABSORPTIOMETRY; PREDICTION AND FORECASTING; RADIOGRAPHY; RANDOMIZED CONTROLLED TRIAL; STATISTICS; UNITED STATES; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ABSORPTIOMETRY, PHOTON; ADIPOSITY; ADOLESCENT; AFRICAN AMERICANS; ANTHROPOMETRY; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BODY MASS INDEX; DOUBLE-BLIND METHOD; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 1; LIPOPROTEINS, HDL; MALE; METFORMIN; OBESITY; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; TOMOGRAPHY, X-RAY COMPUTED; TRIGLYCERIDES; UNITED STATES; WAIST CIRCUMFERENCE;

EID: 75749156607     PISSN: 19307381     EISSN: 1930739X     Source Type: Journal    
DOI: 10.1038/oby.2009.261     Document Type: Article

References (36)

1. Deckelbaum RJ, Williams CL. Childhood obesity: the health issue. Obes Res 2001;9 Suppl 4:239S-243S.
2. Montague C T, O'Rahilly S. The perils of portliness: causes and consequences of visceral adiposity. Diabetes 2000;49:883-888.
3. Asayama K, Dobashi K, Hayashibe H et al. Threshold values of visceral fat measures and their anthropometric alternatives for metabolic derangement in Japanese obese boys. Int J Obes Relat Metab Disord 2002;26:208-213.
4. Fox CS, Massaro JM, Hoffmann U et al. Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study. Circulation 2007;116:39-48. (Pubitemid 47016245)
5. Matsuzawa Y, Nakamura T, Shimomura I, Kotani K. Visceral fat accumulation and cardiovascular disease. Obes Res 1995;3 Suppl 5:645S-647S.
6. De Simone M, Verrotti A, Iughetti L et al. Increased visceral adipose tissue is associated with increased circulating insulin and decreased sex hormone binding globulin levels in massively obese adolescent girls. J Endocrinol Invest 2001;24:438-444.
7. Buemann B, Sørensen TI, Pedersen O et al. Lower-body fat mass as an independent marker of insulin sensitivity-the role of adiponectin. Int J Obes (Lond) 2005;29:624-631.
8. Kuczmarski RJ, Ogden CL, Grummer-Strawn LM et al. CDC growth charts: United States. Adv Data 2000;27.
9. Wang J, Thornton JC, Bari S et al. Comparisons of waist circumferences measured at four sites. Am J Clin Nutr 2003;77:379-384.
10. Anthropometry Procedures Manual. www.cdc.gov/nchs/data/nhanes/ nhanes-03-04/BM.pdf (2000). Accessed February 2008.
11. Burke J P, Hale DE, Hazuda H P, Stern M P. A quantitative scale of acanthosis nigricans. Diabetes Care 1999;22:1655-1659.
12. Borkan GA, Gerzof SG, Robbins AH et al. Assessment of abdominal fat content by computed tomography. Am J Clin Nutr 1982;36:172-177.
13. Matthews DR, Hosker J P, Rudenski AS et al. Homeostasis model assessment: insulin resistance and β-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 1985;28:412-419.
14. Matsuda M, DeFronzo RA. Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 1999;22:1462-1470.
15. Lustig RH, Mietus-Snyder ML, Bacchetti P et al. Insulin dynamics predict body mass index and z-score response to insulin suppression or sensitization pharmacotherapy in obese children. J Pediatr 2006;148:23-29.
16. Sluiter WJ, Erkelens DW, Reitsma WD, Doorenbos H. Glucose tolerance and insulin release, a mathematical approach I. Assay of the β-cell response after oral glucose loading. Diabetes 1976;25:241-244.
17. Després J P, Lemieux I, Bergeron J et al. Abdominal obesity and the metabolic syndrome: contribution to global cardiometabolic risk. Arterioscler Thromb Vasc Biol 2008;28:1039-1049.
18. Hamdy O, Porramatikul S, Al-Ozairi E. Metabolic obesity: the paradox between visceral and subcutaneous fat. Curr Diabetes Rev 2006;2: 367-373.
19. Yki-Jarvinen H, Makimattila S, Utriainen T, Rutanen EM. Portal insulin concentrations rather than insulin sensitivity regulate serum sex hormone-binding globulin and insulin-like growth factor binding protein 1 in vivo. J Clin Endocrinol Metab 1995;80:3227-3232.
20. Travers SH, Labarta JI, Gargosky SE et al. Insulin-like growth factor binding protein-I levels are strongly associated with insulin sensitivity and obesity in early pubertal children. J Clin Endocrinol Metab 1998;83:1935-1939.
21. Buyalos R P, Pekonen F, Halme JK, Judd HL, Rutanen EM. The relationship between circulating androgens, obesity, and hyperinsulinemia on serum insulin-like growth factor binding protein-1 in the polycystic ovarian syndrome. Am J Obstet Gynecol 1995;172:932-939.
22. Yeoh SI, Baxter RC. Metabolic regulation of the growth hormone independent insulin-like growth factor binding protein in human plasma. Acta Endocrinol (Copenh) 1988;119:465-473.
23. Holly JM, Smith C P, Dunger DB et al. Levels of the small insulin-like growth factor-binding protein are strongly related to those of insulin in prepubertal and pubertal children but only weakly so after puberty. J Endocrinol 1989;121:383-387.
24. Motaghedi R, Gujral S, Sinha S et al. Insulin-like growth factor binding protein-1 to screen for insulin resistance in children. Diabetes Technol Ther 2007;9:43-51.
25. Saitoh H, Kamoda T, Nakahara S, Hirano T, Nakamura N. Serum concentrations of insulin, insulin-like growth factor(IGF)-I, IGF binding protein (IGFBP)-1 and-3 and growth hormone binding protein in obese children: fasting IGFBP-1 is suppressed in normoinsulinaemic obese children. Clin Endocrinol (Oxf) 1998;48:487-492.
26. Le Stunff C, Bougneres P. Early changes in postprandial insulin secretion, not in insulin sensitivity, characterize juvenile obesity. Diabetes 1994;43: 696-702.
27. McLaughlin T, Reaven G, Abbasi F et al. Is there a simple way to identify insulin-resistant individuals at increased risk of cardiovascular disease? Am J Cardiol 2005;96:399-404.
28. Mietus-Snyder M. Lipid metabolism in children and adolescents: impact on vascular biology. J Clin Lipidol 2008;2:127-137.
29. Florez H, Mendez A, Casanova-Romero P et al. Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population. Atherosclerosis 2006;188:134-141.
30. Shin MJ, Kanaya AM, Krauss RM. Polymorphisms in the peroxisome proliferator activated receptor-α gene are associated with levels of apolipoprotein CIII and triglyceride in African-Americans but not Caucasians. Atherosclerosis 2008;198:313-319.
31. Lee JM, Okumura MJ, Davis MM, Herman WH, Gurney JG. Prevalence and determinants of insulin resistance among U.S. adolescents: a population-based study. Diabetes Care 2006;29:2427-2432.
32. Hannon TS, Bacha F, Lin Y, Arslanian SA. Hyperinsulinemia in African American (AA) adolescents compared with their American white (AW) peers despite similar insulin sensitivity: a reflection of up-regulated β-cell function? Diabetes Care 2008;31:1445-1447.
33. Arslanian S, Danadian K. Insulin secretion, insulin sensitivity and diabetes in black children. Trends Endocrinol Metab 1998;9:194-199.
34. Preeyasombat C, Bacchetti P, Lazar AA, Lustig RH. Racial and etiopathologic dichotomies in insulin hypersecretion and resistance in obese children. J Pediatr 2005;146:474-481.
35. Jiang X, Srinivasan SR, Radhakrishnamurthy B, Dalferes ER, Berenson GS. Racial (black-white) differences in insulin secretion and clearance in adolescents: the Bogalusa heart study. Pediatrics 1996;97: 357-360. (Pubitemid 26076261)
36. Yeckel CW, Weiss R, Dziura J et al. Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 2004;89:1096-1101.